Potentially Exposed to Measles Infants < 12 months Pregnant patients without documented immunity (MMR, Hx of disease) or + IgGLab Immunocompromised (see.

Slides:



Advertisements
Similar presentations
Patient Centered Medical Home Evans Medical Group 465 North Belair Road 1B Evans Georgia
Advertisements

2009 Pandemic Influenza Preparation Presented by Midland ISD Health Services.
Sharp Healthcare Interpreting Program. agenda 2 » Overview » SIGNS » Education » Web Site.
Case Identification for the Missouri Perinatal Hepatitis B Prevention Program Libby Landrum, RN, MSN Viral Hepatitis Prevention Manager Bureau HIV, STD,
Measles million cases a year worldwide 750,000 deaths (WHO 2002) – half in Africa Accounts for about half of all vaccine preventable deaths.
Maryland Department of Health and Mental Hygiene.
Protect Against Pertussis
Severe combined immune deficiency in Nablus Omar Abuzaitoun, MD.
Group Exercise Infection Control of Aerosol Transmissible Diseases.
What is one of the most contagious diseases? Measles 2015 Dr. Michael Levy.
INTEGRIS Preparedness Plan: Ebola Virus Disease (EVD) With the spread of Ebola to the U.S., ensuring our employees and communities are safe is the utmost.
Measles: Case Study Hiro Landazuri Karla Gonzalez Jonathan Chen.
Common Childhood Diseases. Routine childhood immunization schedule Age at vaccination2 mos4 mos6 mos12 mos18 mos4-6 yrs9-13 yrs14-16 yrs Diptheria 8 Tetanus.
Washington State Hospital Association Medicaid Quality Incentive ER is for Emergencies Medicaid Quality Incentive ER is for Emergencies Web Conference.
* TB is caused by a bacterium called Mycobacterium Tuberculosis. The bacteria usually attacks the lungs, but TB bacteria can attack any part of the.
Adult Immunization 2010 MMR Vaccine Segment This material is in the public domain This information is valid as of May 25, 2010.
Adult Immunization 2010 Herpes Zoster (Shingles) Segment This material is in the public domain This information is valid as of May 25, 2010.
Chickenpox (varicella)
Measles and Measles Vaccine
Measles and Measles Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory Diseases Centers.
Are you having mild fevers? Swollen & tender lymph nodes? A rash that begins on the face & spreads Downwards of your Body?
Developed By: Barbara (Bobbi) P. Clarke, PhD. RD Professor & Extension Health Specialist, Co-Director for The University of Tennessee Center for Community.
Halt and Reverse: HIV/AIDS. History Discovered in 1980s Originally linked to gay males first blood test approved In 1986, AZT, a failed cancer.
H1N1 General Information Update Karen Dahl, MD Pediatric Infectious Diseases.
Copyright Medical Group Management Association. All rights reserved. Name, credentials Organization Date Preparing Your Office Practice for Disaster.
5th Annual Advocacy Project: ImmuneWise Section on Medical Students, Residents, and Fellowship Trainees
Swine Flu Tool Kit Responding to the threat. Principles of Swine Flu Toolkit 1 Rapid Identification of Acute Respiratory Disease Identify Risk Factors.
H1N1 VIRUS SWINE FLU. What is the H1N1 Virus? It is a new virus that is spread from person to person first detected in people in the United States in.
Tuberculosis Egan’s Chapter 22. Mosby items and derived items © 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 2 Tuberculosis (TB) The incidence of.
Component 1: Introduction to Health Care and Public Health in the U.S. Unit 3: Delivering Healthcare (Part 2) Outpatient Care (Retail, Urgent and Emergency.
Component 1: Introduction to Health Care and Public Health in the U.S. Unit 3: Delivering Healthcare (Part 2) Lecture 3 This material was developed by.
BY: MRS. VAN CUREN Pertussis (Whooping Cough). What is Whooping Cough? Whooping cough is an extremely contagious upper respiratory infection. It causes.
Silence Whooping Cough Campaign Pertussis in the Community CDC reports that nationwide pertussis is at a 50 year high Number of cases in Washington.
IMCI This session introduces you to IMCI – Integrated Management of Childhood Illnesses - the strategy introduced in the Philippines in 1995 and known.
Rash Decisions: The Colorado Experience with “Maybe Measles” Emily Spence Davizon, Colorado Department of Public Health and Environment.
 >280 new cases  >38 children hospitalised  Epidemiological statistics - 1 expected case of death when case counts reach to 500  Every new case has.
Student Health Services A User’s Guide. Presentation overview The Basics: Who/What/Where/When/Why After hours Insurance issues H1N1 aka Swine flu Your.
ITT TECHNICAL INSTITUTE SCHOOL OF HEALTH SCIENCES Nursing Department ITT TECHNICAL INSTITUTE SCHOOL OF HEALTH SCIENCES Nursing Department Mandatory Tuberculosis.
1 Novel Influenza A H1N1 Outbreak: The Florida Response Epidemiology Perspective: Situation Update.
MENINGOCOCCAL PNEUMOCOCCAL TETANUS, DIPHTHERIA, PERTUSSIS VARICELLA HEPATITIS A HEPATITIS B HUMAN PAPILLOMA VIRUS Anyone starting at 6 mos old y/o.
Introduction to OraQuick Rapid HIV Testing William F. Ryan Community Health Center School Based Health Program.
Comprehensive Field Record. Introduction to the Training ● The slides will first show a picture of the section of the template that will be discussed.
A Self Study Powerpoint
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
MEASLES: A STORY FROM THE FIELD Jennifer Zipprich, PhD Immunization Branch California Department of Public Health September 15 th, 2015.
Integrated Management of Childhood Illnesses
Viral Hepatitis Program Management of Babies Born to HBsAg- Positive Mothers Vickie Weeast Perinatal Hepatitis B Case.
MENINGOCOCCAL POLYSACCHARIDE PNEUMOCOCCAL POLYSACCHARIDE TETANUS, DIPHTHERIA, PERTUSSIS VARICELLA HEPATITIS A HEPATITIS B HUMAN PAPILLOMA VIRUS Anyone.
Measles Outbreak in Skopje, Republic of Macedonia, 2014 Erjona Shakjiri 1, D. Kochinski 1, Sh. Memeti 1, B. Aleksoski 1, K. Stavridis 1, V. Mikic 1, G.
SECTION I ACTIVE DIAGNOSES January 14, PM.
Dr. Athal Humo transient Passive immunity is achieved by administration of preformed antibodies to induce transient protection against an infectious.
Needlesticks & Exposures 600,000 to one million needle-stick injuries happen every year in the United States. 600,000 to one million needle-stick injuries.
M EASLES (R UBEOLA ) February, 2015Safety Training.
MERS-CoV (Middle Eastern Respiratory Syndrome) Mike Wade – 16/06/15, updated 23/7/15.
MMR is meant to prevent three types of diseases the first is Mumps. Mumps is a viral disease that spreads from person to person by sneezing or coughing.
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. Childhood Immunization.
Adult Immunizations August 23, 2004 Vinod Kurup, MD
Varicella & Pregnancy Dr S. Asadi Infectious diseases specialist
University Actions The University has an infectious disease component within its all-hazards emergency plan. Notify Ventura County Public Health of a suspected.
Quarantine and Isolation During the Sedgwick County
Pathophysiology of Febrile Neutropenia
A Public Health Presentation by Cindy Mui
The Role of the Immunization Registry in a Measles Outreak, New York City The Role of the Immunization Registry in a Measles Outbreak, New York City Ynolde.
Human Health and Disease
Diagnosed Food Handlers
Needlesticks & Exposures
Symptoms of measles include:
By Dr. Satti Abdulrahim Satti Consultant Pediatrician
Smallpox Vaccine Contraindications and Screening
Click on one of the absence types below for more
Presentation transcript:

Potentially Exposed to Measles Infants < 12 months Pregnant patients without documented immunity (MMR, Hx of disease) or + IgGLab Immunocompromised (see Immunocompromised page) Yes and within 6 days of exposure* High Risk? If within 72 hours of exposure, go to av MHS Urgent Care for MMR if no immunity. If beyond 72 hours of exposure, watch for symptoms, recommend immunization at community site. *Exposure Day = Day 0 Example: Day 0 6/24/14 Day 1 6/25/14 Day 2=6/26/14 Day 3=6/27/14 Yes, but beyond 6 day of exposure* Notify physician of exposure Watch for symptoms for three weeks (Symptoms start with a fever, cough, runny nose, red watery eyes); rash will develop a few days later. Generally rash starts on face and spreads downward. Illness may last 7-10 days. If pt develops symptoms, call Drs. Office or Urgent Care for instructions on when and how to be treated. Patients with highly suspicious symptoms should not present directly to clinics or facilities without pre- notification (if at all possible). When and if they do present, follow algorithm posted on MHS net. Notify patients physician Infants < 12 months go to MB ED for Ig IM Pregnant patients go to TG L & D for Ig IV after IgG drawn Immunocompromised patients go to Puyallup Infusion Center (see Immunocompromised page) Not High Risk And Not-Pregnant Pregnant, with documented Immunity are considered immune. Patient should notify obstetrician, but no further treatment or follow-up needed. Measles Treatment Decision Algorithm for Exposed Individuals 6/28/14

Puyallup infusion address: th Ave. S.E. Puyallup, WA Saturday Hours: 830am-5pm Sunday Hours: 830am-1pm For non-MultiCare providers, no exceptions (faxed to ): · Order (attached and links below) o 8%20Immune%20Globulin.pdfhttp://mhsnet/forproviders/good_samaritan_providers/Preprinted%20Orders/Infusion%20Center/ %20Immune%20Globulin.pdf o found on MHSnet > web tools > click “pre-printed orders (Good Samaritan)” > Infusion Center > Immune Globulin · Recent H&P from treating provider · Current medication list · The ordering provider must be credentialed at MultiCare (any MHS hospital) · We prefer that any high-risk pregnancies be referred to the OBED at Good Sam for monitoring during IVIG We have spaces available on both Sat and Sun for infusions, if needed. To schedule, call and ask for the charge nurse to coordinate. Measles Treatment Decision Algorithm Immunocompromised Patients Immune Deficient Conditions Severe Primary Immunodeficiency Patients who have received a bone marrow transplant until at least 12 months after finishing immunosuppressive treatment (or longer in patients who have graft-versus-host disease) Patients on treatment for acute lymphocytic leukemia within and until at least 6 months after completion of immunosuppressive chemotherapy HIV infected persons with severe immunosuppression: CD4 percent 5 years) 6/28/14